Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
About this item
Full title
Author / Creator
Nathan, David M , Lachin, John M , Bebu, Ionut , Burch, Henry B , Buse, John B , Cherrington, Andrea L , Fortmann, Stephen P , Green, Jennifer B , Kahn, Steven E , Kirkman, M Sue , Krause-Steinrauf, Heidi , Larkin, Mary E , Phillips, Lawrence S , Pop-Busui, Rodica , Steffes, Michael , Tiktin, Margaret , Tripputi, Mark , Wexler, Deborah J , Younes, Naji , The GRADE Study Research Group and GRADE Study Research Group
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
In a secondary analysis comparing the effect of insulin glargine, glimepiride, liraglutide, and sitagliptin, added to metformin, on the incidences of microvascular complications and death, no material between-group differences were seen.
Alternative Titles
Full title
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
Authors, Artists and Contributors
Author / Creator
Lachin, John M
Bebu, Ionut
Burch, Henry B
Buse, John B
Cherrington, Andrea L
Fortmann, Stephen P
Green, Jennifer B
Kahn, Steven E
Kirkman, M Sue
Krause-Steinrauf, Heidi
Larkin, Mary E
Phillips, Lawrence S
Pop-Busui, Rodica
Steffes, Michael
Tiktin, Margaret
Tripputi, Mark
Wexler, Deborah J
Younes, Naji
The GRADE Study Research Group
GRADE Study Research Group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9832916
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9832916
Other Identifiers
ISSN
0028-4793,1533-4406
E-ISSN
1533-4406
DOI
10.1056/NEJMoa2200436
